Abstract
Purpose: OnabotulinumtoxinA (BoNT-A) is a promising therapy for treating neurogenic detrusor overactivity (NDO) in individuals with spinal cord injury......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
